326 related articles for article (PubMed ID: 9481747)
21. ANCA associated pauci-immune retinal vasculitis.
Gallagher MJ; Ooi KG; Thomas M; Gavin M
Br J Ophthalmol; 2005 May; 89(5):608-11. PubMed ID: 15834094
[TBL] [Abstract][Full Text] [Related]
22. A familial case of P-ANCA glomerulonephritis presenting in a father and daughter.
Hull CM; Couser WG; Knostman JD
Am J Kidney Dis; 2000 May; 35(5):E23. PubMed ID: 10793052
[TBL] [Abstract][Full Text] [Related]
23. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
Gross WL
Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
[TBL] [Abstract][Full Text] [Related]
24. [Systemic ANCA-associated vasculitis--diagnosis and therapy].
Eisenberger U; Hess C
Ther Umsch; 2008 May; 65(5):295-301. PubMed ID: 18622935
[TBL] [Abstract][Full Text] [Related]
25. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic and pathogenic significance of antineutrophil cytoplasmic antibodies in vasculitides].
Bartůnková J; Tesar V; Fucíková T; Janatková I; Zabka J; Krystůfková O; Rychlík I
Bratisl Lek Listy; 1995 Oct; 96(10):528-33. PubMed ID: 8620323
[TBL] [Abstract][Full Text] [Related]
27. Are environmental factors important in primary systemic vasculitis? A case-control study.
Lane SE; Watts RA; Bentham G; Innes NJ; Scott DG
Arthritis Rheum; 2003 Mar; 48(3):814-23. PubMed ID: 12632437
[TBL] [Abstract][Full Text] [Related]
28. Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan.
Suzuki Y; Takeda Y; Sato D; Kanaguchi Y; Tanaka Y; Kobayashi S; Suzuki K; Hashimoto H; Ozaki S; Horikoshi S; Tomino Y
Mod Rheumatol; 2010 Feb; 20(1):54-62. PubMed ID: 19821007
[TBL] [Abstract][Full Text] [Related]
29. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies.
Tidman M; Olander R; Svalander C; Danielsson D
J Intern Med; 1998 Aug; 244(2):133-41. PubMed ID: 10095799
[TBL] [Abstract][Full Text] [Related]
30. [Rapidly progressive ANCA-negative glomerulonephritis in the course of pauci immune microscopic vasculitis with hemolytic anemia probable in the course of Wilson's disease].
Wieczorek-Surdacka E; Kaczmarczyk I; Jasik P; Przepiórkowska-Hoyer B; Sułowicz W
Przegl Lek; 2011; 68(2):123-5. PubMed ID: 21751523
[TBL] [Abstract][Full Text] [Related]
31. [Rheumatology -- Part 3. Research news concerning epidemiology, diagnosis, and therapy of primary systemic vasculitides].
Lamprecht P; Ahmadi-Simab K; Gross WL; Hellmich B
Med Klin (Munich); 2006 Mar; 101(3):212-25. PubMed ID: 16648979
[TBL] [Abstract][Full Text] [Related]
32. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
Kallenberg CG; Heeringa P; Stegeman CA
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
[TBL] [Abstract][Full Text] [Related]
34. Antineutrophil cytoplasmic antibodies in the classification of vasculitis.
Niles JL
Annu Rev Med; 1996; 47():303-13. PubMed ID: 8712783
[TBL] [Abstract][Full Text] [Related]
35. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group.
Guillevin L; Lhote F; Amouroux J; Gherardi R; Callard P; Casassus P
Br J Rheumatol; 1996 Oct; 35(10):958-64. PubMed ID: 8883433
[TBL] [Abstract][Full Text] [Related]
36. Immunopathology of ANCA-associated vasculitis.
Csernok E; Müller A; Gross WL
Intern Med; 1999 Oct; 38(10):759-65. PubMed ID: 10526937
[TBL] [Abstract][Full Text] [Related]
37. Antineutrophil cytoplasmic antibodies (ANCA).
Radice A; Sinico RA
Autoimmunity; 2005 Feb; 38(1):93-103. PubMed ID: 15804710
[TBL] [Abstract][Full Text] [Related]
38. Thoughts about the classification of small vessel vasculitis.
Falk RJ; Jennette JC
J Nephrol; 2004; 17 Suppl 8():S3-9. PubMed ID: 15599883
[TBL] [Abstract][Full Text] [Related]
39. Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy?
Mandl LA; Solomon DH; Smith EL; Lew RA; Katz JN; Shmerling RH
Arch Intern Med; 2002 Jul; 162(13):1509-14. PubMed ID: 12090888
[TBL] [Abstract][Full Text] [Related]
40. Pauci-immune crescentic glomerulonephritis.
Gupta RK
Indian J Pathol Microbiol; 2003 Jul; 46(3):357-66. PubMed ID: 15025274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
